The most common side effects in clinical studies were [[erythematous rash]]es.<ref name="Drugs.com" />

 


 
A [[boxed warning]] has been added to the safety label to describe an increase rate of death from [[cancer]] when three or more tubes are used.<ref>[http://www.medscape.com/viewarticle/575748?sssdmh=dm1.359512&scr=ddd Medscape Article]</ref>

 
Regranex should be used with caution in patients with known malignancy.<ref>http://www.regranex.com/patient/pdf/PI_full_version.pdf</ref>

 

